| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $39.6M | -31.6% |
| R&D Expense | $112.7M | +1.0% |
| SG&A Expense | $34.9M | -22.0% |
| Operating Income | -$121.2M | -16.6% |
| Pre-tax Income | -$123.5M | -25.9% |
| Income Tax | -$568K | -240.1% |
| Net Income | -$122.9M | -25.5% |
| EPS (Basic) | -$0.44 | +10.2% |
| EPS (Diluted) | -$0.44 | +10.2% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $20.9M | -50.0% |
| Accounts Receivable | $371K | -29.5% |
| Current Assets | $35.8M | -30.7% |
| Total Assets | $59.7M | -41.2% |
| Current Liabilities | $42.5M | -7.3% |
| Total Liabilities | $74.0M | -6.2% |
| Stockholders' Equity | -$14.3M | -162.7% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$97.2M | -44.8% |
| Capital Expenditures | $102K | -61.8% |
| Investing Cash Flow | -$102K | -100.3% |
| Financing Cash Flow | $70.7M | +149.3% |
| Free Cash Flow | -$97.3M | -44.4% |